Selective inhibition of the second bromodomain of BET family proteins results in robust antitumor activity in preclinical models of acute myeloid leukemia
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Selective inhibition of the second bromodomain of BET family proteins is efficacious in preclinical models of AML Overall design: BRD4 ChIP-Seq under three different treatment conditions, H3K27Ac ChIP-Seq control conditions only.
创建时间：
2023-03-24
